Artificial intelligence is not yet able to fully replace human experts in important drug safety work, FDA cautions.
Key Takeaways
-
Causality assessments for adverse events still require human expertise and judgement, US FDA officials say. Pharma should keep this in mind as it explores using AI for case safety reports.
The pharmaceutical industry is exploring the application of AI to the processing of individual case safety reports (ICSR), Center for...